Board approves merger of wholly owned HSCC into NBCC

Strategic Transactions View source PDF Explain this filing

NBCC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹98.08

prior close

₹98.92

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.7%-1.0% vs market

Civil Construction peers, median of 99sector-0.0%-0.3% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Smallcap 250 and 0.3 pts less than its Civil Construction peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.0

15m

+0.2

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.7-1.0-0.0-0.3

Next day

-0.8+0.7-1.6-0.3-0.5

-1.1+0.2-1.2-1.3+0.3

+0.2+0.3-0.0-1.3+1.5

-1.3+0.7-2.0-0.8-0.5

-3.5-0.6-2.9-1.8-1.6

-4.2-2.1-2.1-2.8-1.4

15d

-2.1+1.9-4.1-1.7-0.5

-8.5+1.9-10.4-4.4-4.1

-17.7-0.5-17.3-8.5-9.2

-23.1-1.9-21.1-10.9-12.2

UpDownMarket · Nifty Smallcap 250Sector · Civil Construction peers, median of 99Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NBCC board approved a scheme to merge its wholly owned subsidiary HSCC (India) into NBCC. HSCC, a healthcare infrastructure consultancy under the same Ministry, had FY26 turnover of about Rs 1,850 crore versus NBCC's about Rs 9,755 crore. No new shares or cash will be issued since HSCC is fully owned by NBCC, so shareholding pattern remains unchanged. The merger aims to consolidate operations, cut compliance and admin costs, and simplify the group structure. Subject to MCA and other regulatory approvals.

Likely market impact

No share dilution; simplifies group structure and may lower costs. Subject to regulatory approvals.